- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Mantle Cell Lymphoma Recurrent in United States
Total 6265 results
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMantle Cell LymphomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General HospitalActive, not recruitingMantle Cell LymphomaUnited States
-
University of Alabama at BirminghamTerminated
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); Millennium...Active, not recruitingMantle Cell LymphomaUnited States
-
University of Wisconsin, MadisonCompletedMantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterOnyx Therapeutics, Inc.TerminatedLymphomaUnited States
-
Milton S. Hershey Medical CenterUnknownMantle Cell LymphomaUnited States
-
University of MiamiCompleted
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedLymphoma | Mantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterBiogenCompletedLymphoma, Mantle-CellUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingMantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterAmgen; Pharmacyclics LLC.Terminated
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
Anand JillellaNovartis PharmaceuticalsCompletedMantle Cell LymphomaUnited States
-
Weill Medical College of Cornell UniversityCompleted
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)CompletedRecurrent Adult Burkitt Lymphoma | Recurrent Adult Acute Lymphoblastic Leukemia | B-cell Adult Acute Lymphoblastic Leukemia | Acute Leukemias of Ambiguous Lineage | Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic LeukemiaUnited States
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityNot yet recruitingMantle Cell LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMantle Cell LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
University of Wisconsin, MadisonCompleted
-
Weill Medical College of Cornell UniversityPfizer; Millennium Pharmaceuticals, Inc.TerminatedMantle Cell LymphomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; BiogenCompletedMantle Cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
University of Alabama at BirminghamTerminatedAnaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Peripheral T-cell Lymphomas | Adult T-cell Leukemia | Adult T-cell Lymphoma | Peripheral T-cell Lymphoma Unspecified | T/Null Cell Systemic Type | Cutaneous t-Cell Lymphoma With Nodal/Visceral DiseaseUnited States
-
Acerta Pharma BVAstraZenecaActive, not recruitingMantle Cell Lymphoma (MCL)United States, Poland, Italy
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Chronic Myelomonocytic Leukemia | Juvenile Myelomonocytic Leukemia | Burkitt Lymphoma | Secondary... and other conditionsUnited States
-
Ronald LevyNational Cancer Institute (NCI)Active, not recruitingMantle Cell Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | B-Cell Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Chronic Myelomonocytic Leukemia | Juvenile Myelomonocytic Leukemia | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone... and other conditionsUnited States, Canada
-
University of Wisconsin, MadisonGenentech, Inc.TerminatedMantle Cell Lymphoma | Non Hodgkin Lymphoma | Non-hodgkin LymphomaUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaUnited States
-
University of NebraskaMillennium Pharmaceuticals, Inc.CompletedMantle Cell Lymphoma | Non-hodgkin's LymphomaUnited States
-
Novartis PharmaceuticalsBristol-Myers SquibbRecruitingNon-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone LymphomaUnited States, Germany, Italy, Korea, Republic of, Spain, Singapore, China, Japan, Australia
-
Qilu Puget Sound Biotherapeutics (dba Sound Biologics)RecruitingFollicular Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | MALT Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Indolent Lymphoma | Refractory B-Cell LymphomaUnited States, Australia, China
-
Epizyme, Inc.CompletedFollicular Lymphoma | Marginal Zone Lymphoma | Advanced Solid Tumors | Mantle-Cell Lymphoma | Diffuse Large B Cell Lymphoma | Primary Mediastinal LymphomaUnited Kingdom
-
Sunesis PharmaceuticalsCompletedMultiple Myeloma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | B-lymphoid MalignanciesUnited States
-
Austin I KimAstraZeneca; Genentech, Inc.Recruiting
-
TG Therapeutics, Inc.TerminatedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic LymphomaUnited States, Poland, Australia, Italy, United Kingdom, Israel, Korea, Republic of, Slovakia, Spain
-
Northwestern UniversityAmgenTerminatedRecurrent Cutaneous T-cell Non-Hodgkin Lymphoma | Recurrent Mycosis Fungoides/Sezary Syndrome | Stage III Cutaneous T-cell Non-Hodgkin Lymphoma | Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma | Stage I Cutaneous T-cell Non-Hodgkin Lymphoma | Stage IA Mycosis Fungoides/Sezary Syndrome | Stage... and other conditionsUnited States
-
Hackensack Meridian HealthActive, not recruitingMantle Cell LymphomaUnited States
-
Washington University School of MedicineAcerta Pharma BVActive, not recruitingMantle Cell LymphomaUnited States
-
University of Southern CaliforniaTerminatedMantle Cell LymphomaUnited States
-
VelosBio Inc., a subsidiary of Merck & Co., Inc...CompletedFollicular Lymphoma | Acute Myeloid Leukemia | Burkitt Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma | Acute Lymphoid Leukemia | Richter Transformation Lymphoma | Lymphoplasmacytoid Lymphoma | T-cell Non-Hodgkin...United States
-
Power Life Sciences Inc.Not yet recruiting
-
Washington University School of MedicineCompletedMantle Cell LymphomaUnited States
-
University of Michigan Rogel Cancer CenterWithdrawnMantle Cell LymphomaUnited States
-
Dana-Farber Cancer InstituteTG Therapeutics, Inc.; The Leukemia and Lymphoma Society; Blood Cancer Research...CompletedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
C. Babis AndreadisEli Lilly and Company; Genentech, Inc.; Adaptive BiotechnologiesNot yet recruitingMantle Cell LymphomaUnited States